The Cooley’s Anemia Foundation invites applications for its clinical trials in thalassaemia cell and gene therapy grant. This supports clinical trials in cell and gene therapy to advance a cure for thalassaemia. Both phase I and phase II trials may be supported.
Individuals from all over the globe may apply. Applicants must state the status of their proposed trials.
The grant is worth up to USD 75,000 for a one-year period. Renewal for a second year of funding may be available.
Deadline: 20th December 2019.